ADAP
Price
$0.32
Change
+$0.01 (+3.23%)
Updated
Apr 3 closing price
Capitalization
84.53M
41 days until earnings call
CRBU
Price
$0.79
Change
-$0.07 (-8.14%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
73.02M
39 days until earnings call
Ad is loading...

ADAP vs CRBU

Header iconADAP vs CRBU Comparison
Open Charts ADAP vs CRBUBanner chart's image
Adaptimmune Therapeutics
Price$0.32
Change+$0.01 (+3.23%)
Volume$3.94M
Capitalization84.53M
Caribou Biosciences
Price$0.79
Change-$0.07 (-8.14%)
Volume$15.11K
Capitalization73.02M
ADAP vs CRBU Comparison Chart
Loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAP vs. CRBU commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Hold and CRBU is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ADAP: $0.32 vs. CRBU: $0.79)
Brand notoriety: ADAP and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAP: 211% vs. CRBU: 82%
Market capitalization -- ADAP: $84.53M vs. CRBU: $73.02M
ADAP [@Biotechnology] is valued at $84.53M. CRBU’s [@Biotechnology] market capitalization is $73.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ADAP’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than ADAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 4 bullish TA indicator(s).

  • ADAP’s TA Score: 4 bullish, 4 bearish.
  • CRBU’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADAP and CRBU are a good buy in the short-term.

Price Growth

ADAP (@Biotechnology) experienced а +47.23% price change this week, while CRBU (@Biotechnology) price change was -20.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

ADAP is expected to report earnings on May 15, 2025.

CRBU is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADAP($84.5M) has a higher market cap than CRBU($73M). ADAP YTD gains are higher at: -39.874 vs. CRBU (-45.849). ADAP has higher annual earnings (EBITDA): -55.9M vs. CRBU (-162.69M). CRBU has more cash in the bank: 210M vs. ADAP (186M). CRBU has less debt than ADAP: CRBU (26.5M) vs ADAP (74.5M). ADAP has higher revenues than CRBU: ADAP (175M) vs CRBU (9.99M).
ADAPCRBUADAP / CRBU
Capitalization84.5M73M116%
EBITDA-55.9M-162.69M34%
Gain YTD-39.874-45.84987%
P/E RatioN/AN/A-
Revenue175M9.99M1,751%
Total Cash186M210M89%
Total Debt74.5M26.5M281%
FUNDAMENTALS RATINGS
ADAP: Fundamental Ratings
ADAP
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAPCRBU
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEVDQ0.02N/A
N/A
Nevada Copper Corp.
ALFVY41.71-1.08
-2.52%
Alfa-Laval AB
SOMMY11.50-0.59
-4.88%
Sumitomo Chemical Co., Ltd.
VTYX1.00-0.06
-5.66%
Ventyx Biosciences
KHNGY42.93-2.90
-6.32%
Kuehne & Nagel International AG

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CCCC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+2.37%
CCCC - CRBU
55%
Loosely correlated
+5.92%
FATE - CRBU
54%
Loosely correlated
+1.70%
CRSP - CRBU
52%
Loosely correlated
+3.17%
ALLO - CRBU
52%
Loosely correlated
+5.11%
NKTX - CRBU
51%
Loosely correlated
+3.52%
More